UNMC Radiologist Glenn Dalrymple, 81 

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Glenn Dalrymple, a radiology professor at the University of Nebraska Medical Center from 1990 to 1996, died March 9 in Omaha after a long battle with colon cancer. He was 81.

A native of Little Rock, Ark., Dalrymple spent the early part of his career in Little Rock, spending 16 years on the faculty of the University of Arkansas for Medical Sciences, 11 years in a private practice radiology program, and two years with the John L. McClellan Memorial Veterans Administration Hospital.

He joined UNMC in 1990 as professor of radiology and internal medicine and played an active role in UNMC’s cancer research program. One of his areas of expertise was nuclear medicine, a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease.

He also served as interim chair of the UNMC Department of Radiation Oncology (1993-94) and as interim chair of the department (1994-96). He retired in 1996.

Dalrymple was a captain in the U.S. Air Force, serving as director of the Space Radiation Effects Group, Radiobiology Branch in the School of Aerospace Medicine at Brooks Air Force Base in Texas. His team estimated the radiation risks to astronauts in the early years of the space program.

“He was a man of spectacular intellect, genuine kindness and a deep appreciation for medicine and education,” said Charles Morris, professor of radiology at UNMC. “He was a superb clinician, a prolific researcher in both clinical radiology and radiation biology, and a wonderful teacher.”

Dalrymple had a lifelong commitment to symphonic music. He and his wife of 61 years, Mary Jo, were founders of the Arkansas Symphony Orchestra, and Dalrymple played the French horn and trombone with the ASO for 35 years.

Upon moving to Omaha, the Dalrymples again founded a community symphony. Dalrymple played with Orchestra Omaha for 15 years, including several years with the additional challenge of low vision.

“I considered Dr. Dalrymple to be my greatest mentor and teacher, and most of all, a great friend,” said Nina Baranowska-Kortylewicz, UNMC professor of radiation oncology. “Glenn was a true Renaissance man. He was always an avant-garde when it came to music—he loved Gustav Mahler. He was an innovative photographer, and he left a wonderful legacy for UNMC Radiation Safety by bestowing several of his photographs to the department.”

Dalrymple is survived by his wife, Mary Jo, and children Anne Dalrymple (John Keenan) of Seattle, and Mark Dalrymple (Sharlotte DeVere) of Pittsburgh. He also is survived by one grandchild, Zoe Keenan, of Seattle.

Memorials should be made to the Weigel Williamson Center for Visual Rehabilitation at UNMC, the Nebraska Humane Society, Orchestra Omaha or The Intergeneration Orchestra of Omaha.

MSKCC Researcher Robert Golbey, 93

Robert Golbey, who spent 35 years at Memorial Sloan Kettering Cancer Center, died at his home March 12, with his wife, Monica Hunt, and son, Seth, beside him. He was 93.

After joining MSKCC in 1955, Golbey helped establish and lead the Solid Tumor Service, and implemented studies for the treatment of testicular cancer. Golbey was born in Brooklyn in 1922, and received his medical degree at New York University.

In addition to his medical career, he achieved the rank of brigadier general in the U.S. Army Reserves, and served in the Korean War.

Golbey requested that any remembrances be made in his memory to The Landings Military Relief Fund for Families, or to Hospice Savannah.

YOU MAY BE INTERESTED IN

Shearwood McClelland III’s grandfather was a ditchdigger who dreamed that his six Black daughters would become doctors. McClelland’s mother did not disappoint—she became the first Black woman board-certified in maternal fetal medicine in the history of the United States.  Now, McClelland is the chief medical officer of Cancer Health Equity at the University of Oklahoma...

As oncology enters a new era of precision medicine, the Food and Drug Administration’s evolving biomarker strategy aims to ensure that life-saving therapies are tailored to individual patient needs, fostering safer and more effective treatments.  Historically, therapies were approved with broad indications based on overall efficacy, even when outcomes for biomarker-positive and -negative patients were...

In the evolving landscape of pediatric oncology, survivorship research has become an essential component of our mission to improve long-term patient outcomes. At City of Hope, we are focused on not only curing childhood cancers but also ensuring that survivors live the healthiest lives possible. A significant part of my research has been dedicated to mitigating the long-term toxicities of cancer therapy—particularly cardiovascular complications that can arise decades after treatment.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login